Direct and indirect costs of management of long‐term warfarin therapy in Canada
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (10), 2192-2200
- https://doi.org/10.1111/j.1538-7836.2010.03989.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2009
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogramJournal of Thrombosis and Haemostasis, 2009
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation ClinicsValue in Health, 2008
- The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the USPharmacoEconomics, 2006
- The cost-effectiveness of different management strategies for patients on chronic warfarin therapyJournal of General Internal Medicine, 2000
- Guidelines on oral anticoagulation: third editionBritish Journal of Haematology, 1998
- The Impact of Long-term Warfarin Therapy on Quality of LifeArchives of Internal Medicine, 1991
- Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.Journal of Clinical Pathology, 1990